Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CareDx Inc

    NASDAQ: CDNA · Real-Time Price · USD
    19.04
    0.01 (0.05%)
    At close: Jun 20, 2025, 3:59 PM
    18.74
    -1.58%
    After-hours: Jun 20, 2025, 05:56 PM EDT
    0.05%
    Bid 18.99
    Market Cap 1.06B
    Revenue (ttm) 346.42M
    Net Income (ttm) 58.85M
    EPS (ttm) 1.12
    PE Ratio (ttm) 17
    Forward PE 111.94
    Analyst Buy
    Ask 19.1
    Volume 772,858
    Avg. Volume (20D) 1,048,045
    Open 19.23
    Previous Close 19.03
    Day's Range 18.76 - 19.23
    52-Week Range 13.74 - 34.84
    Beta 2.18

    About CDNA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CDNA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CDNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    CareDx Inc is scheduled to release its earnings on Jul 30, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 weeks ago
    +10.67%
    CareDx shares are trading higher after the company... Unlock content with Pro Subscription
    4 months ago
    +11.16%
    CareDx shares are trading higher after Chevy Chase Trust CIO Amy Raskin disclosed on CNBC's Halftime Report that she has bought the stock.
    news image

    1 week ago · seekingalpha.com

    CareDx: The Transplant Diagnostics Leader, But Challenges Will Increase On The Road Ahead

    CareDx has a unique, comprehensive organ transplant diagnostics portfolio and maintains strong revenue growth, but faces intensifying competition and regulatory risks. Recent legal resolutions and ope...

    news image

    2 weeks ago · businesswire.com

    CareDx Announces Repurchase of 5% of Outstanding Shares

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinica...

    news image

    1 month ago · businesswire.com

    Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

    SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for...

    news image

    1 month ago · businesswire.com

    CareDx to Participate in Upcoming Investor Conferences

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

    news image

    1 month ago · seekingalpha.com

    CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript

    CareDx, Inc (NASDAQ:CDNA ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President & Chief Executive Officer Robert ...

    news image

    1 month ago · zacks.com

    CareDx (CDNA) Tops Q1 Earnings Estimates

    CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago.

    news image

    1 month ago · businesswire.com

    CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

    news image

    2 months ago · businesswire.com

    CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ (“CareDx” or the “Company”)— a leading precision medicine company focused on the discovery, development, and co...

    news image

    2 months ago · businesswire.com

    CareDx to Report First Quarter 2025 Financial Results

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcar...

    news image

    2 months ago · businesswire.com

    CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

    NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its...

    Add to Watchlist